Colin Carlock
The University of Texas Health Science Center at Houston(US)
Publications by Year
Research Areas
PI3K/AKT/mTOR signaling in cancer, Protein Degradation and Inhibitors, Cancer-related gene regulation, Ubiquitin and proteasome pathways, PARP inhibition in cancer therapy
Most-Cited Works
- → Aurora B kinase phosphorylates and instigates degradation of p53(2012)202 cited
- → Effects of Obesity on Transcriptomic Changes and Cancer Hallmarks in Estrogen Receptor–Positive Breast Cancer(2014)116 cited
- → The cell cycle regulator 14-3-3σ opposes and reverses cancer metabolic reprogramming(2015)87 cited
- → Interleukin33 deficiency causes tau abnormality and neurodegeneration with Alzheimer-like symptoms in aged mice(2017)62 cited
- → IL-33 Is Required for Disposal of Unnecessary Cells during Ovarian Atresia through Regulation of Autophagy and Macrophage Migration(2015)57 cited
- → Targeting Plk1 to Enhance Efficacy of Olaparib in Castration-Resistant Prostate Cancer(2017)57 cited
- → Requirement of brain interleukin33 for aquaporin4 expression in astrocytes and glymphatic drainage of abnormal tau(2021)55 cited
- → Unique Temporal and Spatial Expression Patterns of IL-33 in Ovaries during Ovulation and Estrous Cycle Are Associated with Ovarian Tissue Homeostasis(2014)50 cited
- → Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer(2018)41 cited
- → Mechanism of PRL2 phosphatase-mediated PTEN degradation and tumorigenesis(2020)36 cited